Axovant to Participate in Upcoming October Conferences and Provide AXO-Lenti-PD Program Update the Morning of October 6th Oct 5, 2020 07:00AM
Axovant Gene Therapies (AXGT) PT Raised to $15 at Chardan Capital Markets Jun 10, 2020 02:25PM
Axovant Gene Therapies Announces Closing of $74.7 Million Public Offering of Common Shares and Prefunded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Feb 24, 2020 04:01PM
Axovant (AXGT) Prices 14.03M Share Common Offering at $3.75/Sh Feb 20, 2020 05:53AM
Axovant Gene Therapies Announces Pricing of $65 Million Public Offering Feb 19, 2020 10:11PM


Mar 11, 2019 10:34AM Chardan Capital Markets Upgrades Axovant Gene Therapies Ltd. (AXGT) to Buy